Image Guided Therapy

Intrasight

Intrasight

Smart. Simple. Seamless.

Best-in-class interventional tools built for today’s lab, ready for tomorrow’s innovations.

We envision personalized, efficient and clinically smart cardiac care that helps drive optimal outcomes throughout the patient journey. Our vision offers strategic and focused approach, addressing critical cardiac care needs and meeting better health outcomes, lower cost of care and improved patient and staff experience.
That’s why the Philips Interventional Applications Platform — IntraSight Mobile offers a comprehensive suite of clinically proven1-5 imaging and physiology tools on a modern, secure platform.
Secure
With the most robust cybersecurity, which runs on Microsoft Windows 10, providing you with the latest data encryption and protection against cybersecurity threats.

Now available, IntraSight on a mobile platform*

Providing versatility, IntraSight can now be experienced on an easy to maneuver mobile cart for all environments. Ideally suited for acute and non-acute settings. Customize your platform, select the best-in-class imaging and physiology tools that are right for your coronary or peripheral vascular patients. Seamless mobile integration with any interventional suite enabling the use of Philips interventional precision tools.
Intrasight on mobile
*Product availability is subject to country regulatory clearance. Please contact your local sales representative to check availability in your country.
For customers with non-Philips interventional suites, IntraSight 7 offers seamless integration and full use of our interventional applications. IntraSight 7 promotes enhanced workflow management with the tableside touch screen module allowing for ease of use and access to best in class interventional tools such as iFR/FFR, IVUS and co-registration. Additionally, IntraSight 7 integration with non-Philips interventional suites allows customers to benefit from intuitive solutions such as, vessel enhancement and device detection, ultimately allowing all customers to benefit from IntraSight 7’s comprehensive offering of smart solutions without compromise.
IntraSight 7, iFR Co-registration and IVUS Co-registration are not available on IntraSight mobile platform.

Want to learn more about IntraSight?

Stay up-to-date and get informed about interventional cardiology topics. Or get in touch with our sales team.

IntraSight is the only interventional platform that:

iFR physiology

Includes iFR physiology

the gold standard among resting indices, 1,2,7 whichis included in both the AUC (ACC Appropriate UseCriteria)8 and NCDR (National Cardiovascular Data Registry)9 and received a Class IA ESC (EuropeanSociety of Cardiology) guideline10
Combines iFR and IVUS data

Combines iFR and IVUS data

with the angiogram using iFR Co-registration, IVUS Co-registration and Tri-registration features6
Combines iFR and IVUS data

Enables an entire case

to be run tableside without breaking scrub with the touch screen module

Learn how the IntraSight platform is smart, simple, and seamless.

IntraSight is smart

Built on a smart, applications-based platform that can scale to meet the evolving needs of your lab when new applications or modalities become available, without the need to purchase new hardware. Only Philips Interventional Applications Platform - IntraSight,6 offers best-in-class imaging and physiology tools with iFR, iFR Co-registration, FFR, IVUS, IVUS Co-registration, and Angio+. With its modular architecture, IntraSight stays on top of latest advances and important security updates.

Single access point with a shared touch screen module with IntraSight and Azurion.

Azurion
iFR utilize

Utilize iFR

the gold standard among resting indices because it’s backed by patient outcomes, that reduces costs, procedural time and patient discomfort1-3 while providing advance guidance with co-registration. With iFR Co-registration there is no need for hyperemic drugs and no need for guesswork.
IVUS

Utilize IVUS

is “definitely beneficial” for patients,11 and resulted in a change of treatment plans 74% of the time.12
Combines iFR and IVUS data

Secure and safe

First interventional platform to run on Microsoft Windows 10, providing the latest data encryption and advanced protection against cybersecurity threats. Usernames/passwords controlled by administrator and system auto logout safter timeout.

IntraSight is simple


Delivering an outstanding user experience with a modern, intuitive interface that minimizes learning curves and increases workflow confidence.

Easy-to-use because you can:

  • Navigate and measure faster with an intuitive user interface and enhanced measurement tools (Video 1)
  • Facilitate faster training without using a catheter or wire in the all new demonstration mode
  • Save time and reduce frustration with faster workflows and faster transitions between iFR, IVUS and co-registration6 (Video 2)
  • Utilize new snapshot and reporting features
Azurion
Video 1
Video intrasight thumbnail
Video 2

IntraSight is seamless


Optimizing lab performance with tableside touchscreen control, systems integration, data management and remote service diagnostics

Increase case efficiency, save time and reduce errors with seamless data

 

  • Run an entire case tableside with a new touch screen module (Image 1)
  • Enter patient information once with a single case menu that is shared between iFR/FFR and IVUS modalities (Image 2)
  • Seamless integration of patient information with Philips’ Allura and Azurion iXR systems
  • Integrate iFR or IVUS modalities with the angiogram using iFR Co-registration and IVUS Co-registration6
  • Import patient info from Philips Azurion or Allura coronary suites with a touch of a button and non-Philips cath labs with DICOM worklists
  • Philips Remote Services (PRS) keep systems running smoothly with remote diagnosing, corrective action planning and improved uptime
Intrasight azurion touch screen
Image 1
Intrasight single case meu
Image 2

IntraSight series configurations

  •  
    IntraSight Interventional applications platform

    IntraSight  

    • Best-in-class imaging, physiology and co-registration tools (with IntraSight 7 configuration)
    • Modern and intuitive interface minimizes learning curves and increases workflow confidence
    • Optimize performance with data management, remote service diagnostics and cybersecurity protection
    IGTDINTRSGHT
  •  
    IntraSight Mobile Interventional applications platform

    IntraSight Mobile  

    • Choice of FFR, iFR, and IVUS modalities
    • Windows 10 security
    • New, versatile touch screen module
    IGTDINTRSGHTMBL
*

Contact information

* This field is mandatory
*
*
*
*
*
*
*
*
*
By specifying your reason for contact we will be able to provide you with a better service.
We work with partners and distributors who may contact you about this Philips product on our behalf.
*
*

Philips apreciază şi respectă confidenţialitatea clienţilor săi. Vă puteţi retrage permisiunile în orice moment. Pentru mai multe informaţii, citiţi Politica de confidenţialitate Philips.

Product availability is subject to country regulatory clearance. Please contact your local sales representative to check availability in your country.

 

1. Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR andFFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017.

2. Gotberg M, et al., iFR-SWEDEHEART Investigators.. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017 May 11;376(19):1813-18233.

3. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.

4. A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487-1503.

5. Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing ComplexProcedures. JACC: Cardiovascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227.

6. Co-registration tools available within IntraSight 7 configuration via SyncVision.

7. 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and Europeanassociation for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96.

8. Patel M, et al., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients with Stable Ischemic HeartDisease. J Am Coll Cardiol. 2017 May 2;69(17):2212-2241.

9. ACC CathPCI Hospital Registry.

10. Lofti A, et al. Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the societyof cardiac angiography and interventions. Catheter Cardiovasc Interv. 2018;1–12.

11. Lotfi, A., Davies, J. E., Fearon, W. F., Grines, C. L., Kern, M. J., & Klein, L. W. (2018). Focused update of expert consensus statement: Use of invasive assessments ofcoronary physiology and structure: A position statement of the society of cardiac angiography and interventions. Catheterization and cardiovascular interventions :official journal of the Society for Cardiac Angiography & Interventions, 92(2), 336–347.

12. Witzenbichler B, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: The ADAPT-DES study. Circulation.2014 Jan:129,4;463-470.

Azurion

Let's get connected


#futureofIGT, #futureofCAD, #IntraSight, #CoronaryIntervention, #seeclearlytreatoptimally, #IVUS

 

How would you improve interventional procedures?

What do you think about the new IntraSight Platform?

Are we on the right track?

 

Connect with us via #futureofIGT / IntraSight

Philips Healthcare

Follow Philips Healthcare

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.